Managed Access Agreements- A New Model Pathway for The Reimbursement of Non-Oncology Drugs in England Approved Under European Adaptive Pathways?
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.922
https://www.valueinhealthjournal.com/article/S1098-3015(16)32288-4/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
866
First Page :
A505
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32288-4&doi=10.1016/j.jval.2016.09.922